SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Childs who wrote (2079)11/5/1997 6:26:00 PM
From: Don Dunlap  Respond to of 23519
 
TA, Great to here you are buying again! You have timed this stock beatifully in the past. Perhaps we are nearing bottom.



To: Steve Childs who wrote (2079)11/5/1997 6:33:00 PM
From: Tunica Albuginea  Read Replies (1) | Respond to of 23519
 
The ED # of patients reference is from the 1993 National Institutes of Health Consensus Conference were they estimated 10-20 mill of SEVERE,
ORGANIC ED. These patients ARE UNLIKELY TO RESPOND TO VIAGRA. If you include " minimal ED", ( that would a large no of psychogenic ED ),
then the figure rises to 30 mill.In these men, Viagra is more likely to work( that is in these extra 10 mill ).

TA


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News